Primary Biliary Cholangitis (PBC) Clinical Trials

12 recruiting

Frequently Asked Questions

Common questions about Primary Biliary Cholangitis (PBC) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 3

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Primary Biliary Cholangitis (PBC)
Ipsen276 enrolled177 locationsNCT06016842
Recruiting
Phase 1Phase 2

A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction

Primary Biliary Cholangitis (PBC)
Umecrine Cognition AB84 enrolled36 locationsNCT07304843
Recruiting

Biochemical Response and Clinical Outcomes in Patients With PBC

Primary Biliary CholangitisPrimary Biliary Cholangitis (PBC)
RenJi Hospital3,000 enrolled1 locationNCT07449793
Recruiting
Phase 3

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases150 enrolled1 locationNCT06755541
Recruiting
Phase 3

Fenofibrate in Primary Biliary Cholangitis: a Real World Study

Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases300 enrolled1 locationNCT06755151
Recruiting
Phase 3

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases132 enrolled1 locationNCT07296458
Recruiting

Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)

Primary Biliary Cholangitis (PBC)
Hospital Universitario La Paz80 enrolled1 locationNCT07205874
Recruiting
Not Applicable

RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis

Primary Biliary Cholangitis (PBC)
Hospital Clinic of Barcelona64 enrolled1 locationNCT07161245
Recruiting

PBC Long-term Outcomes Study

PrognosisPrimary Biliary Cholangitis (PBC)Long-term Outcomes+1 more
Beijing Friendship Hospital4,000 enrolled1 locationNCT07149675
Recruiting
Early Phase 1

Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases15 enrolled1 locationNCT07104201
Recruiting
Not Applicable

EMPower Mechanisms

Primary Biliary Cholangitis (PBC)
University of Alberta20 enrolled1 locationNCT06861465
Recruiting

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

Primary Sclerosing Cholangitis (PSC)Primary Biliary Cholangitis (PBC)Hepatitis Autoimmune Disease+1 more
Asociación Española para el Estudio del Hígado5,000 enrolled1 locationNCT06767605